Abstract

Intestinal barrier immaturity, or “leaky gut”, is the proximate cause of susceptibility to necrotizing enterocolitis in preterm neonates. Exacerbated intestinal immune responses, gut microbiota dysbiosis, and heightened barrier injury are considered primary triggers of aberrant intestinal maturation in early life. Inordinate host immunity contributes to this process, but the precise elements remain largely uncharacterized, leaving a significant knowledge gap in the biological underpinnings of gut maturation. In this study, we investigated the fecal cytokine profile and gut microbiota in a cohort of 40 early preterm infants <33-weeks-gestation to identify immune markers of intestinal barrier maturation. Three distinct microbiota types were demonstrated to be differentially associated with intestinal permeability (IP), maternal breast milk feeding, and immunological profiles. The Staphylococcus epidermidis- and Enterobacteriaceae-predominant microbiota types were associated with an elevated IP, reduced breast milk feeding, and less defined fecal cytokine profile. On the other hand, a lower IP was associated with increased levels of fecal IL-1α/β and a microbiota type that included a wide array of anaerobes with expanded fermentative capacity. Our study demonstrated the critical role of both immunological and microbiological factors in the early development of intestinal barrier that collectively shape the intestinal microenvironment influencing gut homeostasis and postnatal intestinal maturation in early preterm newborns.

Highlights

  • A functional intestinal barrier is not just a static physical boundary but a dynamic, interactive tissue structure that combines a cellular barrier with chemical, immunological, and microbiological components [1, 2]

  • We previously reported an astonishing 42.5% prevalence of persistently elevated intestinal permeability (IP) in early preterm infants (

  • We employed a cohort of 40 early preterm newborns 24 weeks (240/7)-32 weeks and 6 days (326/7) of gestation recruited at the Neonatal Intensive Care Unit (NICU) of University of Maryland Medical Center in Baltimore, Maryland

Read more

Summary

Introduction

A functional intestinal barrier is not just a static physical boundary but a dynamic, interactive tissue structure that combines a cellular barrier with chemical, immunological, and microbiological components [1, 2]. The human intestinal epithelium harbors multiple specialized cell types and is supported by a diverse population of underlying immune cells; the tissue arrangement, interaction, and function are controlled by intricate cell contact-mediated signals and distinct cytokines and molecular mediators in the local microenvironment [2, 3]. A community of diverse microorganisms inhabiting the gastrointestinal tract, collectively referred as gut microbiota, contributes to intestinal homeostasis and overall health [4]. It is well-accepted that the intestinal microbiota is established concurrently with the developing mucosal immunological barrier after birth [1, 5–8], it has been argued that the human microbiota may develop even earlier in the prenatal intrauterine environment [9–12]. The communications between epithelial cells, immune cells, and gut microbiota orchestrate immune responses to specific antigens and balance tolerance; these processes evolve through the different stages of life to accommodate host developmental needs [2, 7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call